(NewsDirect)
Emyria Ltd (ASX:EMD)MD Michael Winlo speaks with Proactive after announcing the companyhas received strong support for its recent placement, securing firmcommitments from new and sophisticated investors to raise $2 million(before costs). Alongside the oversubscribed placement, Emyria is alsoundertaking an entitlement offer to raise around $3.1 million at thesame terms. Emyria intends to use the funds raised from the placementand entitlement offer to support its strategic objectives in mentalhealthcare, particularly in new drug development and in addressing theneeds of the estimated 400,000 Australians impacted by severePTSD.
Winlo said,"We're thrilled by the strong support for our recentplacement, particularly from our long-term investors. We'reequally excited to extend the same investment terms to ourshareholders through an entitlement offer.
"This capital will advance our mentalhealthcare programs, especially our efforts to combat severe PTSD, andaccelerate our drug development initiatives.
"Emyria's unique approach serves patients grapplingwith complex mental health issues while generating revenues andreal-world data to lay a solid foundation for our future growth andinnovation.”
ContactDetails
Proactive Investors
JonathanJackson
+61 413 713 744
Jonathan@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.